Literature DB >> 27190114

Hyperimmunoglobulinaemia D syndrome: a rare cause of prolonged fever and treatment with anti-interleukin 1 agent.

Deniz Aygun1, Sezgin Sahin2, Haluk Cokugras1, Ozgur Kasapcopur2.   

Abstract

Hyperimmunoglobulinaemia D syndrome (HIDS) is an autosomal recessive, autoinflammatory disease that is characterised with intermittent febrile episodes, cervical lymphadenopathy, rashes, arthritis and gastrointestinal symptoms associated with synovial or serosal inflammation. HIDS is caused by mutations in the gene encoding mevalonate kinase enzyme. The febrile attacks usually start in early childhood and triggered by stress or vaccinations. We report a case of 16-month-old boy who had episodes of recurrent fever accompanied by maculopapular rash and lymphadenopathy. He was diagnosed as HIDS and he had heterozygote mutation of mevalonate kinase gene. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27190114      PMCID: PMC4885411          DOI: 10.1136/bcr-2016-214941

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.

Authors:  Anne Musters; Paul Peter Tak; Dominique L P Baeten; Sander W Tas
Journal:  BMJ Case Rep       Date:  2015-10-29

2.  Autoinflammatory gene mutations in Behçet's disease.

Authors:  I Koné-Paut; E Sanchez; A Le Quellec; R Manna; I Touitou
Journal:  Ann Rheum Dis       Date:  2007-01-09       Impact factor: 19.103

3.  Hereditary periodic fever with systemic amyloidosis: is hyper-IgD syndrome really a benign disease?

Authors:  Rainer Siewert; Jörg Ferber; Rolf Dieter Horstmann; Christof Specker; Peter Julius Heering; Christian Timmann
Journal:  Am J Kidney Dis       Date:  2006-09       Impact factor: 8.860

4.  Different clinical presentation of the hyperimmunoglobulin D syndrome (HIDS) (four cases from Turkey).

Authors:  Dıdem Arslan Tas; Suzan Dınkcı; Eren Erken
Journal:  Clin Rheumatol       Date:  2012-01-14       Impact factor: 2.980

5.  Hyperimmunoglobulinaemia D and periodic fever: a new syndrome.

Authors:  J W van der Meer; J M Vossen; J Radl; J A van Nieuwkoop; C J Meyer; S Lobatto; R van Furth
Journal:  Lancet       Date:  1984-05-19       Impact factor: 79.321

Review 6.  Hyperimmunoglobulin D syndrome in childhood.

Authors:  Jeroen C H van der Hilst; Joost Frenkel
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

Review 7.  Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group.

Authors:  J P Drenth; C J Haagsma; J W van der Meer
Journal:  Medicine (Baltimore)       Date:  1994-05       Impact factor: 1.889

8.  Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome.

Authors:  W Ammouri; L Cuisset; S Rouaghe; M-O Rolland; M Delpech; G Grateau; N Ravet
Journal:  Rheumatology (Oxford)       Date:  2007-09-05       Impact factor: 7.580

9.  Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.

Authors:  Jeroen C H van der Hilst; Evelien J Bodar; Karyl S Barron; Joost Frenkel; Joost P H Drenth; Jos W M van der Meer; Anna Simon
Journal:  Medicine (Baltimore)       Date:  2008-11       Impact factor: 1.889

10.  Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.

Authors:  J P Drenth; M van Deuren; J van der Ven-Jongekrijg; C G Schalkwijk; J W van der Meer
Journal:  Blood       Date:  1995-06-15       Impact factor: 22.113

View more
  1 in total

1.  A case report of mevalonate kinase deficiency in a 14-month-old female with fevers and lower extremity weakness.

Authors:  Tiziana Coppola; Bradford Becken; Heather Van Mater; Marie Theresa McDonald; Gabriela Maradiaga Panayotti
Journal:  BMC Pediatr       Date:  2019-07-20       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.